Friday, 13 Apr 2012 | Posted By:
| Source: CNBC.com
Sanofi-Aventis has been quick to move before its patents on bestselling products expired, said CEO Chris Viehbacher.
Thursday, 5 Apr 2012 | Posted By:
| Source: CNBC.com
Despite a dismal quarter for deal-making to start the year, signs point toward a ramp up in mergers and acquisitions over the rest of 2012.
Wednesday, 8 Feb 2012 | Source: Reuters
French drugmaker Sanofi on Wednesday reported a 13 percent rise in fourth-quarter profit as the contribution of Genzyme and emerging markets offset patent losses and the impact of austerity measures in Europe.
Tuesday, 10 Jan 2012 | Posted By:
| Source: CNBC.com
Chief executives at some of the biggest U.S. biotech and pharmaceutical companies are at the annual JPMorgan health care conference in San Francisco. Here's what some of them told CNBC on Tuesday.
Posts |
COMPANY : Sanofi-Aventis SA
16 Mar 2012
Take a look at some of Friday morning’s early movers:... Read More
15 Mar 2012
Take a look at some of Thursday morning’s early movers:... Read More
24 Feb 2012
Speculation has its place, but Cramer's researcher thinks there is lots of opportunity to profit from established companies, too.... Read More
27 Jan 2012
Cramer thinks big pharma stocks could soon pop, so here's his preferred plays.... Read More
VIDEO | COMPANIES : Sanofi-Aventis SA
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Mitul Kotecha, Head of Global FX Strategy at Credit Agricole, says euro-dollar could reach 1.20 in the medium-term, but ...
Jiong Shao, Chief China Strategist, Macquarie discusses Alibaba Group's decision to buy back a 20 percent stake held by ...
Emerging markets turn negative for the year. Could the U.S. selloff be mirroring the dip in the emerging markets? Tim Se...
A look at the market moving activities across Europe, including continued weakness in Greek banks and Spanish bonds, wit...
More Videos
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
